- Pfizer Inc PFE and BioNTech SE BNTX will provide the U.S. government additional 500 million doses of its COVID-19 vaccine.
- The doses at a not-for-profit price will be used for donations to low- and lower-middle-income countries and the organizations that support them.
- The expanded agreement brings the total number of doses to be supplied to the U.S. government for donation to these countries to one billion.
- Related Link: Cashing COVID-19 Vaccine - AstraZeneca Or Pfizer.
- Deliveries of the initial 500 million doses began in August 2021, and a total of one billion doses under the expanded agreement are expected to be delivered by the end of September 2022.
- The current plan is to produce these doses in Pfizer's U.S. facilities in Kalamazoo, MI, Andover, MA, Chesterfield, MO, and McPherson, KS.
- Overall, Pfizer and BioNTech have shipped more than 1.5 billion COVID-19 vaccine doses worldwide.
- Citing sources familiar with the issue, Reuters reported that the government would pay some $7 per dose.
- In June, the Biden administration agreed to buy and donate 500 million doses of the vaccine. Under the terms of that contract, the U.S. will pay Pfizer and BioNTech around $3.5 billion or $7/dose.
- Price Action: PFE stock is up 0.27% at $44.04, and BNTX stock is up 0.10% at $341.7 during the premarket session on the last check Wednesday.
- Image by torstensimon from Pixabay
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in